$CURR CURE Pharmaceutical Secures Chinese Patent o
Post# of 103049
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced the allowance of Chinese Patent No. ZL201480039313.6. The new patent covers the loading of high amounts of active drug on an oral thin film using its proprietary drug delivery systems, including its lead drug product, CUREfilm Blue™, a soluble thin film for oral administration of sildenafil citrate (Viagra™) to treat erectile dysfunction (ED) in China. “Securing this key patent supports our global commercialization strategy for CUREfilm Blue as well as follow-on drugs delivered using thin film,” said Rob Davidson, CEO of CURE Pharmaceutical.
https://finance.yahoo.com/news/cure-pharmaceu...10371.html